awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38214976-2352F940-F6BA-4EFE-B17F-255F0DCC49B6
Q38214976-2352F940-F6BA-4EFE-B17F-255F0DCC49B6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38214976-2352F940-F6BA-4EFE-B17F-255F0DCC49B6
Current management and future perspectives of metastatic renal cell carcinoma.
P2860
Q38214976-2352F940-F6BA-4EFE-B17F-255F0DCC49B6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38214976-2352F940-F6BA-4EFE-B17F-255F0DCC49B6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cf4ba3b9302ad629bf49eafc7e050b79e135563f
P2860
Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma.